Protect The Heart Tablet Treatment Of Angina Pectoris Qi Deficiency And Blood Stasis Syndrome Of Clinical Research

Method:1. The 60 patients from clinic and hospital with angina pectoris were randomly divided into treatment group and control group patients; two groups in gender, age, duration of angina pectoris and other aspects of the disease showed no significant difference (P> 0.05), it is comparable; treatment group on the basis of western medicine,oral Huxinkang tablets for four weeks, the control group were treated with Western medicine only.2. Observed the symptoms, signs, significant efficiency and total efficiency before and after the treatment, and statistical analysis to compare their efficacy.3. Laboratory with blood, urine, stool, liver and kidney function as a safety indicator.4. Electrocardiogram before and after treatment compared two groups of ST segment, T wave changes, and whether there is ectopic rhythm, atrioventricular block or intraventricular conduction delay.Results:1. The treatment group compared with the control group, clinical efficacy between the two groups, the total effective relief of angina, nitroglycerin reduced the rate of the stopping conditions,traditional Chinese medicine syndromes and ECG wasstatistically significant (p <0.05).2. The treatment group compared with the control group, blood examination between the two groups (CHO, TG) was not significant (p>0.05).Conclusion:1. Hxinkang tablets for the treatment coronary heart disease (angina pectoris) is safe and effective.2. Huxinkang tablets can improve the onset of angina and quality of life.